ClinicalTrials.gov
ClinicalTrials.gov Menu

Safety Study of Combined Immunotherapy With Trastuzumab and Cetuximab in Patients With Metastatic Breast Cancer

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00367250
Recruitment Status : Unknown
Verified September 2010 by Medical University of Vienna.
Recruitment status was:  Recruiting
First Posted : August 22, 2006
Last Update Posted : September 28, 2010
Sponsor:
Information provided by:
Medical University of Vienna

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Unknown
  Estimated Primary Completion Date : June 2011
  Estimated Study Completion Date : June 2011